Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

Bile acid sequestrants: glucose-lowering mechanisms and efficacy in type 2 diabetes

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Current Therapies That Modify Glucagon Secretion: What Is the Therapeutic Effect of Such Modifications?

    Research output: Contribution to journalReviewResearchpeer-review

  2. Can Cardiovascular Epidemiology and Clinical Trials Close the Risk Management Gap Between Diabetes and Prediabetes?

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Reporting Severe Hypoglycemia in Type 1 Diabetes: Facts and Pitfalls

    Research output: Contribution to journalReviewResearchpeer-review

  4. Metabolomic Biomarkers in the Progression to Type 1 Diabetes

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Diabetic Nephropathy in Women With Preexisting Diabetes: From Pregnancy Planning to Breastfeeding

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Non-alcoholic fatty liver disease alters expression of genes governing hepatic nitrogen conversion

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. The Liver-α-Cell Axis and Type 2 Diabetes

    Research output: Contribution to journalReviewResearchpeer-review

  3. Evaluation of clinical translatability of the diet-induced obese and biopsy-confirmed gubra amylin mouse model of non-alcoholic steatohepatitis

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

  4. Gluco-metabolic effects of oral and intravenous alcohol administration in men

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Endogenous glucose-dependent insulinotropic polypeptide exerts diverging and tissue specific in obese patients with type 2 diabetes

    Research output: Contribution to journalConference abstract in journalResearchpeer-review

View graph of relations

Bile acids are synthesized in the liver from cholesterol and have traditionally been recognized for their role in absorption of lipids and in cholesterol homeostasis. In recent years, however, bile acids have emerged as metabolic signaling molecules that are involved in the regulation of lipid and glucose metabolism, and possibly energy homeostasis, through activation of the bile acid receptors farnesoid X receptor (FXR) and TGR5. Bile acid sequestrants (BASs) constitute a class of drugs that bind bile acids in the intestine to form a nonabsorbable complex resulting in interruption of the enterohepatic circulation. This increases bile acid synthesis and consequently reduces serum low-density lipoprotein cholesterol. Also, BASs improve glycemic control in patients with type 2 diabetes. Despite a growing understanding of the impact of BASs on glucose metabolism, the mechanisms behind their glucose-lowering effect in patients with type 2 diabetes remain unclear. This article offers a review of the mechanisms behind the glucose-lowering effect of BASs, and the efficacy of BASs in the treatment of type 2 diabetes.

Original languageEnglish
JournalCurrent Diabetes Reports
Volume14
Issue number5
Pages (from-to)482
ISSN1534-4827
DOIs
Publication statusPublished - May 2014

ID: 44428215